Related references
Note: Only part of the references are listed.Community-Associated Extended-Spectrum β-Lactamase-Producing Escherichia coli Infection in the United States
Yohei Doi et al.
CLINICAL INFECTIOUS DISEASES (2013)
Extended-spectrum cephalosporin-resistant gram-negative organisms in livestock: An emerging problem for human health?
Salome N. Seiffert et al.
DRUG RESISTANCE UPDATES (2013)
CMY-2-Producing Escherichia coli in the Nose of Pigs
Andrea Endimiani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Transmission Dynamics of Extended-Spectrum β-lactamase-Producing Enterobacteriaceae in the Tertiary Care Hospital and the Household Setting
Markus Hilty et al.
CLINICAL INFECTIOUS DISEASES (2012)
First countrywide survey of third-generation cephalosporin-resistant Escherichia coli from broilers, swine, and cattle in Switzerland
Andrea Endimiani et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Epidemiology and Risk Factors of Community Onset Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli Strains
Cheol-In Kang et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Community-onset healthcare-related urinary tract infections: Comparison with community and hospital-acquired urinary tract infections
Silvia Aguilar-Duran et al.
JOURNAL OF INFECTION (2012)
Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC β-lactamases
Jesus Rodriguez-Bano et al.
JOURNAL OF INFECTION (2012)
Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting
A. Kronenberg et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
A set of multiplex PCRs for genotypic detection of extended-spectrum β-lactamases, carbapenemases, plasmid-mediated AmpC β-lactamases and OXA β-lactamases
Guido M. Voets et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Hospital antibiotic consumption in Switzerland: comparison of a multicultural country with Europe
C. Pluess-Suard et al.
JOURNAL OF HOSPITAL INFECTION (2011)
Community-Onset Bacteremia Due to Extended-Spectrum beta-Lactamase-Producing Escherichia coli: Risk Factors and Prognosis
Jesus Rodriguez-Bano et al.
CLINICAL INFECTIOUS DISEASES (2010)
Changing prevalence of Escherichia coli with CTX-M-type extended-spectrum β-lactamases in outpatient urinary E. coli between 2003 and 2008
Chao Qi et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients: a comparison of two surveys with a 5 year interval
C. D. J. den Heijer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype
Rikke Lind Jorgensen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Nationwide survey of extended-spectrum β-lactamase-producing Enterobacteriaceae in the French community setting
C. Arpin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting
Teresa C. Horan et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2008)
Community infections caused by extended-spectrum β-lactamase-producing Escherichia coli
Jesus Rodriguez-Bano et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women:: emerging multidrug resistance phenotypes
Pak-Leung Ho et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Extended-spectrum β-lactamases of the CTX-M type now in Switzerland
Marie-Frederique Lartigue et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Share Paper
